Showing results (61-70 of 94) with videos related to
Sort By:
Pageof 10
Psychiatry Investigation|August 7, 2024
Effect of Low-Intensity Transcranial Focused Ultrasound Stimulation in Patients With Major Depressive Disorder: A Randomized, Double-Blind, Sham-Controlled Clinical TrialJooyoung Oh, Jin Sun Ryu, Junhyung Kim, et al.Neuroscience Letters|December 25, 2012
Small-world networks in individuals at ultra-high risk for psychosis and first-episode schizophrenia during a working memory taskKyungun Jhung, Sung-Hwan Cho, Ji-Hyun Jang, et al.Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Synthesis of 5'-substituted fluoro-neplanocin A analogues: importance of a hydrogen bonding donor at 5'-position for the inhibitory activity of S-adenosylhomocysteine hydrolaseHyung Ryong Moon, Hyun Joo Lee, Kyung Ran Kim, et al.Nucleic Acids Symposium Series (2004)|September 9, 2008
Synthesis and antiviral evaluation of conformationally fixed bicyclohexanyl nucleosides with ethenyl group at C3'-positionWon Hee Kim, Kyung Ran Kim, Ah-Young Park, et al.Journal of Korean Medical Science|November 28, 2023
Complications of the Central Nervous System in Pediatric Patients With Common Cold Coronavirus Infection During 2014-2019Hwanhee Park, Kyung-Ran Kim, Hee Jae Huh, et al.Schizophrenia Research|April 14, 2015
Impaired facial emotion recognition in individuals at ultra-high risk for psychosis and with first-episode schizophrenia, and their associations with neurocognitive deficits and self-reported schizotypySu Young Lee, Minji Bang, Kyung Ran Kim, et al.The Journal of Nervous and Mental Disease|February 1, 2011
Coping strategies and their relationship to psychopathologies in people at ultra high-risk for psychosis and with schizophreniaSu Young Lee, Kyung Ran Kim, Jin Young Park, et al.Molecular Therapy. Methods & Clinical Development|July 31, 2020
AAV-Mediated Combination Gene Therapy for Neuropathic Pain: GAD65, GDNF, and IL-10Daewook Kim, Kyung-Ran Kim, Yejin Kwon, et al.Early Intervention in Psychiatry|May 4, 2011
Clinical efficacy of individual cognitive therapy in reducing psychiatric symptoms in people at ultra-high risk for psychosisKyung Ran Kim, Su Young Lee, Jee In Kang, et al.Schizophrenia Bulletin|April 17, 2013
Reduced binding potential of GABA-A/benzodiazepine receptors in individuals at ultra-high risk for psychosis: an [18F]-fluoroflumazenil positron emission tomography studyJee In Kang, Hae-Jeong Park, Se Joo Kim, et al.Pageof 10